L30 MH111000/MH/NIMH NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2014	1
2016	1
2017	8
2018	8
2019	3
2024	0

1

The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis.

Wilkinson ST, Ballard ED, Bloch MH, Mathew SJ, Murrough JW, Feder A, Sos P, Wang G, Zarate CA Jr, Sanacora G. Wilkinson ST, et al. Am J Psychiatry. 2018 Feb 1;175(2):150-158. doi: 10.1176/appi.ajp.2017.17040472. Epub 2017 Oct 3. Am J Psychiatry. 2018. PMID: 28969441 Free PMC article. Review.

2

KETAMINE: A POTENTIAL RAPID-ACTING ANTISUICIDAL AGENT?

Wilkinson ST, Sanacora G. Wilkinson ST, et al. Depress Anxiety. 2016 Aug;33(8):711-7. doi: 10.1002/da.22498. Epub 2016 Apr 15. Depress Anxiety. 2016. PMID: 27082101 Free PMC article. Review.

3

Problems with the medicalization of marijuana.

Wilkinson ST, D'Souza DC. Wilkinson ST, et al. JAMA. 2014 Jun 18;311(23):2377-8. doi: 10.1001/jama.2014.6175. JAMA. 2014. PMID: 24845238 Free PMC article. No abstract available.

4

Electroconvulsive Therapy at a Veterans Health Administration Medical Center.

Wilkinson ST, Rosenheck RA. Wilkinson ST, et al. J ECT. 2017 Dec;33(4):249-252. doi: 10.1097/YCT.0000000000000400. J ECT. 2017. PMID: 28272097 Free PMC article.

5

Identifying Recipients of Electroconvulsive Therapy: Data From Privately Insured Americans.

Wilkinson ST, Agbese E, Leslie DL, Rosenheck RA. Wilkinson ST, et al. Psychiatr Serv. 2018 May 1;69(5):542-548. doi: 10.1176/appi.ps.201700364. Epub 2018 Feb 1. Psychiatr Serv. 2018. PMID: 29385954 Free PMC article.

6

Leveraging Neuroplasticity to Enhance Adaptive Learning: The Potential for Synergistic Somatic-Behavioral Treatment Combinations to Improve Clinical Outcomes in Depression.

Wilkinson ST, Holtzheimer PE, Gao S, Kirwin DS, Price RB. Wilkinson ST, et al. Biol Psychiatry. 2019 Mar 15;85(6):454-465. doi: 10.1016/j.biopsych.2018.09.004. Epub 2018 Sep 20. Biol Psychiatry. 2019. PMID: 30528745 Free PMC article. Review.

7

Concurrent use of ketamine and monoamine oxidase inhibitors in the treatment of depression: A letter to the editor.

Katz RB, Toprak M, Wilkinson ST, Sanacora G, Ostroff R. Katz RB, et al. Gen Hosp Psychiatry. 2018 Sep-Oct;54:62-64. doi: 10.1016/j.genhosppsych.2018.05.007. Epub 2018 May 22. Gen Hosp Psychiatry. 2018. PMID: 30100209 Free PMC article. No abstract available.

8

Serum and plasma brain-derived neurotrophic factor and response in a randomized controlled trial of riluzole for treatment resistant depression.

Wilkinson ST, Kiselycznyk C, Banasr M, Webler RD, Haile C, Mathew SJ. Wilkinson ST, et al. J Affect Disord. 2018 Dec 1;241:514-518. doi: 10.1016/j.jad.2018.08.075. Epub 2018 Aug 18. J Affect Disord. 2018. PMID: 30153634 Free PMC article. Clinical Trial.

9

Acute and Longer-Term Outcomes Using Ketamine as a Clinical Treatment at the Yale Psychiatric Hospital.

Wilkinson ST, Katz RB, Toprak M, Webler R, Ostroff RB, Sanacora G. Wilkinson ST, et al. J Clin Psychiatry. 2018 Jul 24;79(4):17m11731. doi: 10.4088/JCP.17m11731. J Clin Psychiatry. 2018. PMID: 30063304 Free PMC article. Clinical Trial.

10

Considerations on the Off-label Use of Ketamine as a Treatment for Mood Disorders.

Wilkinson ST, Sanacora G. Wilkinson ST, et al. JAMA. 2017 Sep 5;318(9):793-794. doi: 10.1001/jama.2017.10697. JAMA. 2017. PMID: 28806440 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

17 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year